Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

Statin-based treatments reduce cardiovascular disease (CVD) risk in patients with non-dialysis chronic kidney disease (CKD), but it is unclear which regimen is the most cost-effective. We used the Study of Heart and Renal Protection (SHARP) CKD-CVD policy model to evaluate the effect of statins and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Kidney Int
Hlavní autoři: Schlackow, Iryna, Kent, Seamus, Herrington, William, Emberson, Jonathan, Haynes, Richard, Reith, Christina, Collins, Rory, Landray, Martin J., Gray, Alastair, Baigent, Colin, Mihaylova, Borislava
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595178/
https://ncbi.nlm.nih.gov/pubmed/31005271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2019.01.028
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky